ABEO insider trades & Congress trades
Abeona Therapeutics Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 5 open-market insider transactions in Abeona Therapeutics Inc. (ABEO) (0 purchases with code P and 5 sales with code S), the most recent on September 29, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 5 sales by 5 ($296K).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,191 | $5.16 | $47K | −0.1% |
| Sep 29, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 6,727 | $5.16 | $35K | −0.1% |
| Sep 29, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 4,902 | $5.16 | $25K | −0.1% |
| Sep 29, 2026 | Seshadri Vishwas | Chief Executive Officer | Sell | 19,608 | $5.16 | $101K | −0.1% |
| Sep 1, 2026 | Alvino Mark | – | Sell | 15,000 | $5.86 | $88K | −0.2% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.